Symbol
| S100A6
| contributors: mct/npt - updated : 24-12-2012
|
HGNC name
| S100 calcium binding protein A6
|
HGNC id
| 10496
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
|  
|  
| --over
|  
|
in primary colorectal adenocarcinomas with liver metastases | tumoral
|  
|  
| --over
|  
|
in osteosarcoma cells loss of its expression correlates with a metastatic phenotype | constitutional
|  
|  
| --over
|  
|
overexpressed in neurodegenerative disorders and a proposed marker for Amyotrophic Lateral Sclerosis (ALS) | constitutional
|  
|  
|  
| gain of function
|
upregulation of astrocytic S100A6 in response to extracellular glutamate may be involved in neuronal damage under pathophysiological conditions | |
Variant & Polymorphism
|
| |
Candidate gene
Marker
| proposed marker for Amyotrophic Lateral Sclerosis (ALS) | Therapy target
|
System | Type | Disorder | Pubmed |
cancer | digestive | liver | |
with SPP1, may be promising diagnostic markers and therapeutic targets for hepatocellular carcinoma |
| | |